BlackRock Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $3.17M | Sell |
45,057
-300,086
| -87% | -$21.1M | ﹤0.01% | 1262 |
|
|
2016
Q3 | $24.5M | Buy |
345,143
+2,114
| +0.6% | +$150K | 0.03% | 437 |
|
|
2016
Q2 | $16.8M | Buy |
343,029
+1,147
| +0.3% | +$56.1K | 0.02% | 571 |
|
|
2016
Q1 | $21.6M | Sell |
341,882
-218,512
| -39% | -$13.8M | 0.02% | 511 |
|
|
2015
Q4 | $62.9M | Sell |
560,394
-13,820
| -2% | -$1.55M | 0.07% | 273 |
|
|
2015
Q3 | $55.3M | Buy |
574,214
+108,177
| +23% | +$10.4M | 0.06% | 279 |
|
|
2015
Q2 | $47.7M | Buy |
466,037
+18,881
| +4% | +$1.93M | 0.05% | 310 |
|
|
2015
Q1 | $27.8M | Buy |
447,156
+13,048
| +3% | +$810K | 0.03% | 451 |
|
|
2014
Q4 | $19M | Sell |
434,108
-2,545
| -0.6% | -$112K | 0.02% | 558 |
|
|
2014
Q3 | $24.7M | Buy |
436,653
+410,015
| +1,539% | +$23.2M | 0.02% | 508 |
|
|
2014
Q2 | $1.2M | Sell |
26,638
-63,584
| -70% | -$2.85M | ﹤0.01% | 1357 |
|
|
2014
Q1 | $4.41M | Buy |
+90,222
| New | +$4.41M | ﹤0.01% | 982 |
|